A Unique Spumavirus Gag N-terminal Domain with Functional Properties of Orthoretroviral Matrix and Capsid

PLoS Pathogens

Volumn 9, Issue 5, 2013, Pages

  Goldstone, David C ^a,c   Flower, Thomas G ^a   Ball, Neil J ^a   Sanz Ramos, Marta ^a   Yap, Melvyn W ^a   Ogrodowicz, Roksana W ^a   Stanke, Nicole ^b   Reh, Juliane ^b   Lindemann, Dirk ^b   Stoye, Jonathan P ^a   Taylor, Ian A ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BIOINFORMATICS; GEL PERMEATION CHROMATOGRAPHY; NONHUMAN; ORTHOREOVIRUS; PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; SPUMA VIRUS; ULTRACENTRIFUGATION; VIRUS CAPSID; VIRUS INFECTIVITY; VIRUS RELEASE; VIRUS REPLICATION;

AMINO ACID SEQUENCE; BIOLOGICAL EVOLUTION; CAPSID; CELL LINE; GENE PRODUCTS, GAG; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; SIMIAN FOAMY VIRUS; TRANSFECTION;

HUMAN SPUMARETROVIRUS; MIRIDAE; SPUMARETROVIRINAE; SPUMAVIRUS;

EID: 84878404212     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003376     Document Type: Article

References (104)

1. Lecellier CH, Saib A, (2000) Foamy viruses: between retroviruses and pararetroviruses. Virology 271: 1-8.
2. Herchenroder O, Renne R, Loncar D, Cobb EK, Murthy KK, et al. (1994) Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology 201: 187-199.
3. Bieniasz PD, Rethwilm A, Pitman R, Daniel MD, Chrystie I, et al. (1995) A comparative study of higher primate foamy viruses, including a new virus from a gorilla. Virology 207: 217-228.
4. Broussard SR, Comuzzie AG, Leighton KL, Leland MM, Whitehead EM, et al. (1997) Characterization of new simian foamy viruses from African nonhuman primates. Virology 237: 349-359.
5. Saib A, (2003) Non-primate foamy viruses. Curr Top Microbiol Immunol 277: 197-211.
6. Riggs JL, Oshirls, Taylor DO, Lennette EH, (1969) Syncytium-forming agent isolated from domestic cats. Nature 222: 1190-1191.
7. Fabricant CG, Rich LJ, Gillespie JH, (1969) Feline viruses. XI. Isolation of a virus similar to a myxovirus from cats in which urolithiasis was experimentally induced. The Cornell veterinarian 59: 667-672.
8. Malmquist WA, Van der Maaten MJ, Boothe AD, (1969) Isolation, immunodiffusion, immunofluorescence, and electron microscopy of a syncytial virus of lymphosarcomatous and apparently normal cattle. Cancer research 29: 188-200.
9. Tobaly-Tapiero J, Bittoun P, Neves M, Guillemin MC, Lecellier CH, et al. (2000) Isolation and characterization of an equine foamy virus. J Virol 74: 4064-4073.
10. Flanagan M, (1992) Isolation of a spumavirus from a sheep. Australian veterinary journal 69: 112-113.
11. Katzourakis A, Gifford RJ, Tristem M, Gilbert MT, Pybus OG, (2009) Macroevolution of complex retroviruses. Science 325: 1512.
12. Han GZ, Worobey M, (2012) An endogenous foamy virus in the aye-aye (Daubentonia madagascariensis). Journal of virology 86: 7696-7698.
13. Han GZ, Worobey M, (2012) An endogenous foamy-like viral element in the coelacanth genome. PLoS pathogens 8: e1002790.
14. Switzer WM, Bhullar V, Shanmugam V, Cong ME, Parekh B, et al. (2004) Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J Virol 78: 2780-2789.
15. Heneine W, Schweizer M, Sandstrom P, Folks T, (2003) Human infection with foamy viruses. Curr Top Microbiol Immunol 277: 181-196.
16. Herchenroder O, Turek R, Neumann-Haefelin D, Rethwilm A, Schneider J, (1995) Infectious proviral clones of chimpanzee foamy virus (SFVcpz) generated by long PCR reveal close functional relatedness to human foamy virus. Virology 214: 685-689.
17. Achong BG, Mansell PWA, Epstein MA, Clifford P, (1971) An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst 46: 299-307.
18. Epstein MA, (2004) Simian retroviral infections in human beings. Lancet 364: 138-139; author reply 139-140.
19. Rethwilm A, (2010) Molecular biology of foamy viruses. Med Microbiol Immunol 199: 197-207.
20. Meiering CD, Linial ML, (2001) Historical perspective of foamy virus epidemiology and infection. Clin Microbiol Rev 14: 165-176.
21. Murray SM, Picker LJ, Axthelm MK, Hudkins K, Alpers CE, et al. (2008) Replication in a superficial epithelial cell niche explains the lack of pathogenicity of primate foamy virus infections. J Virol 82: 5981-5985.
22. Murray SM, Linial ML, (2006) Foamy virus infection in primates. J Med Primatol 35: 225-235.
23. Lindemann D, Rethwilm A, (2011) Foamy virus biology and its application for vector development. Viruses 3: 561-585.
24. Yu SF, Baldwin DN, Gwynn SR, Yendapalli S, Linial ML, (1996) Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science 271: 1579-1582.
25. Moebes A, Enssle J, Bieniasz PD, Heinkelein M, Lindemann D, et al. (1997) Human foamy virus reverse transcription that occurs late in the viral replication cycle. J Virol 71: 7305-7311.
26. Löchelt M, Flügel RM, (1996) The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein. J Virol 70: 1033-1040.
27. Enssle J, Jordan I, Mauer B, Rethwilm A, (1996) Foamy virus reverse transcriptase is expressed independently from the Gag protein. Proc Natl Acad Sci U S A 93: 4137-4141.
28. Flügel RM, Pfrepper KI, (2003) Proteolytic processing of foamy virus Gag and Pol proteins. Curr Top Microbiol Immunol 277: 63-88.
29. Wilk T, Geiselhart V, Frech M, Fuller SD, Flugel RM, et al. (2001) Specific interaction of a novel foamy virus Env leader protein with the N-terminal Gag domain. J Virol 75: 7995-8007.
30. Pietschmann T, Heinkelein M, Heldmann M, Zentgraf H, Rethwilm A, et al. (1999) Foamy virus capsids require the cognate envelope protein for particle export. J Virol 73: 2613-2621.
31. Lindemann D, Pietschmann T, Picard-Maureau M, Berg A, Heinkelein M, et al. (2001) A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. J Virol 75: 5762-5771.
32. Sfakianos JN, LaCasse RA, Hunter E, (2003) The M-PMV cytoplasmic targeting-retention signal directs nascent Gag polypeptides to a pericentriolar region of the cell. Traffic 4: 660-670.
33. Yu SF, Eastman SW, Linial ML, (2006) Foamy virus capsid assembly occurs at a pericentriolar region through a cytoplasmic targeting/retention signal in Gag. Traffic 7: 966-977.
34. Eastman SW, Linial ML, (2001) Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly. J Virol 75: 6857-6864.
35. Pacheco B, Finzi A, McGee-Estrada K, Sodroski J, (2010) Species-specific inhibition of foamy viruses from South American monkeys by New World Monkey TRIM5{alpha} proteins. J Virol 84: 4095-4099.
36. Yap MW, Lindemann D, Stanke N, Reh J, Westphal D, et al. (2008) Restriction of foamy viruses by primate Trim5alpha. J Virol 82: 5429-5439.
37. Stremlau M, Perron M, Lee M, Li Y, Song B, et al. (2006) Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci U S A 103: 5514-5519.
38. Kingston RL, Fitzon-Ostendorp T, Eisenmesser EZ, Schatz GW, Vogt VM, et al. (2000) Structure and self-association of the Rous sarcoma virus capsid protein. Structure Fold Des 8: 617-628.
39. Mortuza GB, Haire LF, Stevens A, Smerdon SJ, Stoye JP, et al. (2004) High-resolution structure of a retroviral capsid hexameric amino-terminal domain. Nature 431: 481-485.
40. Mortuza GB, Dodding MP, Goldstone DC, Haire LF, Stoye JP, et al. (2008) Structure of B-MLV capsid amino-terminal domain reveals key features of viral tropism, gag assembly and core formation. J Mol Biol 376: 1493-1508.
41. Cornilescu CC, Bouamr F, Yao X, Carter C, Tjandra N, (2001) Structural analysis of the N-terminal domain of the human T-cell leukemia virus capsid protein. J Mol Biol 306: 783-797.
42. Gamble TR, Vajdos FF, Yoo S, Worthylake DK, Houseweart M, et al. (1996) Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87: 1285-1294.
43. Jin Z, Jin L, Peterson DL, Lawson CL, (1999) Model for lentivirus capsid core assembly based on crystal dimers of EIAV p26. J Mol Biol 286: 83-93.
44. Gamble TR, Yoo S, Vajdos FF, von Schwedler UK, Worthylake DK, et al. (1997) Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 278: 849-853.
45. Khorasanizadeh S, Campos-Olivas R, Summers MF, (1999) Solution structure of the capsid protein from the human T-cell leukemia virus type-I. J Mol Biol 291: 491-505.
46. Campos-Olivas R, Newman JL, Summers MF, (2000) Solution structure and dynamics of the Rous sarcoma virus capsid protein and comparison with capsid proteins of other retroviruses. J Mol Biol 296: 633-649.
47. Gitti RK, Lee BM, Walker J, Summers MF, Yoo S, et al. (1996) Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 273: 231-235.
48. Holm L, Sander C, (1995) Dali: a network tool for protein structure comparison. Trends Biochem Sci 20: 478-480.
49. Krissinel E, Henrick K, (2004) Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D Biol Crystallogr 60: 2256-2268.
50. Worthylake DK, Wang H, Yoo S, Sundquist WI, Hill CP, (1999) Structures of the HIV-1 capsid protein dimerization domain at 2.6 A resolution. Acta Crystallogr D Biol Crystallogr 55 (Pt 1): 85-92.
51. Pornillos O, Ganser-Pornillos BK, Kelly BN, Hua Y, Whitby FG, et al. (2009) X-ray structures of the hexameric building block of the HIV capsid. Cell 137: 1282-1292.
52. Fischer N, Heinkelein M, Lindemann D, Enssle J, Baum C, et al. (1998) Foamy virus particle formation. J Virol 72: 1610-1615.
53. Cartellieri M, Herchenroder O, Rudolph W, Heinkelein M, Lindemann D, et al. (2005) N-terminal Gag domain required for foamy virus particle assembly and export. J Virol 79: 12464-12476.
54. Life RB, Lee EG, Eastman SW, Linial ML, (2008) Mutations in the amino terminus of foamy virus Gag disrupt morphology and infectivity but do not target assembly. J Virol 82: 6109-6119.
55. Ohkura S, Goldstone DC, Yap MW, Holden-Dye K, Taylor IA, et al. (2011) Novel escape mutants suggest an extensive TRIM5alpha binding site spanning the entire outer surface of the murine leukemia virus capsid protein. PLoS Pathog 7: e1002011.
56. Bryant M, Ratner L, (1990) Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc Natl Acad Sci U S A 87: 523-527.
57. Rein A, McClure MR, Rice NR, Luftig RB, Schultz AM, (1986) Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc Natl Acad Sci U S A 83: 7246-7250.
58. Murray PS, Li Z, Wang J, Tang CL, Honig B, et al. (2005) Retroviral matrix domains share electrostatic homology: models for membrane binding function throughout the viral life cycle. Structure 13: 1521-1531.
59. Conte MR, Klikova M, Hunter E, Ruml T, Matthews S, (1997) The three-dimensional solution structure of the matrix protein from the type D retrovirus, the Mason-Pfizer monkey virus, and implications for the morphology of retroviral assembly. Embo J 16: 5819-5826.
60. Hatanaka H, Iourin O, Rao Z, Fry E, Kingsman A, et al. (2002) Structure of equine infectious anemia virus matrix protein. J Virol 76: 1876-1883.
61. Rao Z, Belyaev AS, Fry E, Roy P, Jones IM, et al. (1995) Crystal structure of SIV matrix antigen and implications for virus assembly. Nature 378: 743-747.
62. Riffel N, Harlos K, Iourin O, Rao Z, Kingsman A, et al. (2002) Atomic resolution structure of Moloney murine leukemia virus matrix protein and its relationship to other retroviral matrix proteins. Structure 10: 1627-1636.
63. Hill CP, Worthylake D, Bancroft DP, Christensen AM, Sundquist WI, (1996) Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc Natl Acad Sci U S A 93: 3099-3104.
64. Saad JS, Miller J, Tai J, Kim A, Ghanam RH, et al. (2006) Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc Natl Acad Sci U S A 103: 11364-11369.
65. Prchal J, Srb P, Hunter E, Ruml T, Hrabal R, (2012) The structure of myristoylated mason-pfizer monkey virus matrix protein and the role of phosphatidylinositol-(4,5)-bisphosphate in its membrane binding. Journal of molecular biology 423: 427-438.
66. Vlach J, Srb P, Prchal J, Grocky M, Lang J, et al. (2009) Nonmyristoylated matrix protein from the Mason-Pfizer monkey virus forms oligomers. Journal of molecular biology 390: 967-980.
67. Rayne F, Kajava AV, Lalanne J, Mamoun RZ, (2004) In vivo homodimerisation of HTLV-1 Gag and MA gives clues to the retroviral capsid and TM envelope protein arrangement. Journal of molecular biology 343: 903-916.
68. Wynne SA, Crowther RA, Leslie AG, (1999) The crystal structure of the human hepatitis B virus capsid. Mol Cell 3: 771-780.
69. Choi G, Park S, Choi B, Hong S, Lee J, et al. (1999) Identification of a cytoplasmic targeting/retention signal in a retroviral Gag polyprotein. J Virol 73: 5431-5437.
70. Rhee SS, Hunter E, (1990) A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus. Cell 63: 77-86.
71. Swiersy A, Wiek C, Zentgraf H, Lindemann D, (2012) Characterization and manipulation of foamy virus membrane interactions. Cell Microbiol 15: 227-36.
72. Lanman J, Lam TT, Barnes S, Sakalian M, Emmett MR, et al. (2003) Identification of novel interactions in HIV-1 capsid protein assembly by high-resolution mass spectrometry. J Mol Biol 325: 759-772.
73. Byeon IJ, Meng X, Jung J, Zhao G, Yang R, et al. (2009) Structural convergence between Cryo-EM and NMR reveals intersubunit interactions critical for HIV-1 capsid function. Cell 139: 780-790.
74. Tobaly-Tapiero J, Bittoun P, Giron ML, Neves M, Koken M, et al. (2001) Human foamy virus capsid formation requires an interaction domain in the N terminus of Gag. J Virol 75: 4367-4375.
75. Mannigel I, Stange A, Zentgraf H, Lindemann D, (2007) Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome. J Virol 81: 3317-3326.
76. Pertel T, Hausmann S, Morger D, Zuger S, Guerra J, et al. (2011) TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472: 361-365.
77. Ganser-Pornillos BK, Chandrasekaran V, Pornillos O, Sodroski JG, Sundquist WI, et al. (2011) Hexagonal assembly of a restricting TRIM5{alpha} protein. Proc Natl Acad Sci U S A 108: 534-539.
78. Rasheed S, Nelson-Rees WA, Toth EM, Arnstein P, Gardner MB, (1974) Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 33: 1027-1033.
79. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, et al. (1987) Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7: 379-387.
80. Heinkelein M, Dressler M, Jarmy G, Rammling M, Imrich H, et al. (2002) Improved primate foamy virus vectors and packaging constructs. J Virol 76: 3774-3783.
81. Stirnnagel K, Luftenegger D, Stange A, Swiersy A, Mullers E, et al. (2010) Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles. Retrovirology 7: 45.
82. Ohkura S, Yap MW, Sheldon T, Stoye JP, (2006) All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction. J Virol 80: 8554-8565.
83. Bock M, Bishop KN, Towers G, Stoye JP, (2000) Use of a transient assay for studying the genetic determinants of Fv1 restriction. J Virol 74: 7422-7430.
84. Müllers E, Uhlig T, Stirnnagel K, Fiebig U, Zentgraf H, et al. (2011) Novel functions of prototype foamy virus Gag glycine- arginine-rich boxes in reverse transcription and particle morphogenesis. J Virol 85: 1452-1463.
85. Ho YP, Schnabel V, Swiersy A, Stirnnagel K, Lindemann D, (2012) A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors. Molecular therapy: the journal of the American Society of Gene Therapy 20: 1167-1176.
86. Stange A, Luftenegger D, Reh J, Weissenhorn W, Lindemann D, (2008) Subviral particle release determinants of prototype foamy virus. J Virol 82: 9858-9869.
87. Stange A, Mannigel I, Peters K, Heinkelein M, Stanke N, et al. (2005) Characterization of prototype foamy virus gag late assembly domain motifs and their role in particle egress and infectivity. J Virol 79: 5466-5476.
88. Doublie S, (1997) Preparation of selenomethionyl proteins for phase determination. Methods in enzymology 276: 523-530.
89. Laue TM, Shah BD, Ridgeway TM, Pelletier SL (1992) Computer-aided interpretation of analytical sedimentation data for proteins. In: Harding SE, Rowe AJ, Horton JC, editors. Analytical Ultracentrifugation in Biochemistry and Polymer Science. Cambridge, United Kingdom: The Royal Society of Chemistry. pp. 90-125.
90. Schuck P, Perugini MA, Gonzales NR, Howlett GJ, Schubert D, (2002) Size-distribution analysis of proteins by analytical ultracentrifugation: strategies and application to model systems. Biophys J 82: 1096-1111.
91. Schuck P, (2000) Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys J 78: 1606-1619.
92. Brown PH, Schuck P, (2006) Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation. Biophys J 90: 4651-4661.
93. Vistica J, Dam J, Balbo A, Yikilmaz E, Mariuzza RA, et al. (2004) Sedimentation equilibrium analysis of protein interactions with global implicit mass conservation constraints and systematic noise decomposition. Anal Biochem 326: 234-256.
94. Schuck P, (2003) On the analysis of protein self-association by sedimentation velocity analytical ultracentrifugation. Anal Biochem 320: 104-124.
95. Kelly RC, Jensen DE, von Hippel PH, (1976) DNA "melting" proteins. IV. Fluorescence measurements of binding parameters for bacteriophage T4 gene 32-protein to mono-, oligo-, and polynucleotides. J Biol Chem 251: 7240-7250.
96. Taylor IA, McIntosh PB, Pala P, Treiber MK, Howell S, et al. (2000) Characterization of the DNA-binding domains from the yeast cell-cycle transcription factors Mbp1 and Swi4. Biochemistry 39: 3943-3954.
97. Otwinowski Z, Minor W, (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276: 307-326.
98. Zwart PH, Afonine PV, Grosse-Kunstleve RW, Hung LW, Ioerger TR, et al. (2008) Automated structure solution with the PHENIX suite. Methods Mol Biol 426: 419-435.
99. Morris RJ, Perrakis A, Lamzin VS, (2003) ARP/wARP and automatic interpretation of protein electron density maps. Methods Enzymol 374: 229-244.
100. Emsley P, Cowtan K, (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126-2132.
101. Painter J, Merritt EA, (2006) Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr D Biol Crystallogr 62: 439-450.
102. Kabsch W, (2010) Xds. Acta crystallographica Section D, Biological crystallography 66: 125-132.
103. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, et al. (2007) Phaser crystallographic software. Journal of Applied Crystallography 40: 658-674.
104. Murshudov GN, Vagin AA, Dodson EJ, (1997) Refinement of Macromolecular Structures by the Maximum-Likelihood Method. Acta Crystallogr D Biol Crystallogr 53 (Pt 3): 240-255.